Peginterferon alfa-2a monotherapy more effective than lamivudine in treatment of chronic hepatitis B

News
Article

Peginterferon alfa-2a monotherapy demonstrated superior end-of-follow-up response rates to peginterferon alfa-2 in combination with lamivudine.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.